NCT04943627 2022-10-05Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)Agenus Inc.Phase 3 Withdrawn
NCT02795884 2016-12-30Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR MutationYonsei UniversityPhase 3 Withdrawn
NCT00055887 2013-05-10Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung CancerSpectrum Pharmaceuticals, IncPhase 3 Withdrawn